JPRN-jRCT1041200075招募中2 期
Randomized phase II study of preceding radiofrequency ablation to atezolizuma plus bevacizumab combination therapy for the patients with unresectable hepatocellular carcinoma
Yamashita Tatsuya0 个研究点目标入组 66 人开始时间: 2020年12月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •clinically diagnosed as hepatocellular carcinoma; unsuitable for local therapy; previously treated by systemic therapy; Preserved liver function; 20 years or older; ECOG Performance status <=2; preservation of major organ function; written informed consent
排除标准
- •refractory ascites or pleural effusion; unsuitable for RFA, risky varices; double cancer; metastases to central nervous system; severe complication; pregnant or lactating women, or women of childbearing potential; mental disorder; patients who investigator regards as inappropriate for candidate
研究者
相似试验
尚未招募
2 期
Study of Chlorophllin for reducing chemotherapy and radiotherapy treatment side effects in head and neck cancersCTRI/2023/07/055047Tata Memorial Hospital
招募中
2 期
A phase II study of consolidative radiotherapy for residual lesions during osimertinib monotherapy (ORIHALCON trial/WJOG13920L)JPRN-jRCTs041220115Kenmotsu Hirotsugu76
进行中（未招募）
不适用
?Estudio Clínico en Fase II aleatorizado de radioterapia, hormonoterapia y quimioterapia con docetaxel versus radioterapia y hormonoterapia, en pacientes afectados de cáncer de próstata localizado de alto riesgo (Estadio III Y IV)?PACIENTES AFECTADOS DE CÁNCER DE PRÓSTATA LOCALIZADO DE ALTO RIESGO (ESTADIO III Y IV)EUCTR2008-003554-14-ESGrupo Español de Tratamiento de Tumores Urológicos (SOGUG)
尚未招募
不适用
A comparative study of surgeries done for treatment of varicosities in patients of varicose vein patients.CTRI/2020/03/024298Department of General Surgery
进行中（未招募）
1 期
A randomised Phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemo-radiation with an embedded Phase II trial for patients with a poor early response using positron emission tomography (PET)on operable oesophageal cancer patientsMedDRA version: 19.1Level: LLTClassification code 10030151Term: Oesophageal cancerSystem Organ Class: 100000004864EUCTR2015-001740-11-GBVelindre NHS Trust